Anxiety Disorders Completed Phase 3 Trials for Quetiapine (DB01224)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00389064Efficacy and Safety Study of Seroquel SR in the Treatment of Generalised Anxiety DisorderTreatment
NCT00534599Generalized Anxiety Disorder Adjunct StudyTreatment
NCT00671853Quetiapine Extended Release (XR) in Bipolar Patients With Comorbid Generalized Anxiety Disorder (GAD)Treatment